International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Domperidone 5 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2021 - Volume 25, Number 6
View All Articles in Issue

Page(s): 500

Domperidone 5 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Domperidone 5 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, peripherally selective dopamine D2 receptor antagonist, selective D2 blocker, domperidone, oral suspension, formulation, gastroesophageal reflux disease, GERD, upper gastrointestinal motility disorders, dopamine adverse effects, nausea and vomiting, emesis, antiemetic, gastroprokinetic agent, galactagogue

Related Categories: FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Domperidone 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 500
Domperidone 5 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2019 Pg. 316
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Use of Domperidone as a Prokinetic and Antiemetic Albright Lisa M	Mar/Apr 2005 Pg. 120-125 View Sample
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O	Sep/Oct 2016 Pg. 426-434
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Domperidone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 61
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
The Treatment of Canine Atopic Disease Davidson Gigi S	May/Jun 2002 Pg. 210-215
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Phan Ha, DeReese Annie, Day A J, Carvalho Maria	May/Jun 2014 Pg. 203-207
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494